Unknown

Dataset Information

0

Effectiveness of treating depression with eye movement desensitization and reprocessing among inpatients-A follow-up study over 12 months.


ABSTRACT: Increasing prevalence of depression poses a huge challenge to the healthcare systems, and the success rates of current standard therapies are limited. While 30% of treated patients do not experience a full remission after treatment, more than 75% of patients suffer from recurrent depressive episodes. Eye Movement Desensitization and Reprocessing (EMDR) therapy represents an emerging treatment option of depression, and preliminary studies show promising effects with a probably higher remission rate when compared to control-therapies such as cognitive behavioral therapy. In the present study, 49 patients with severe depression were treated with an integrated systemic treatment approach including EMDR therapy that followed a specific protocol with a treatment algorithm for depression in a naturalistic hospital setting. Following their discharge from the hospital, the patients were followed up by a structured telephone interview after 3 and 12 months. 27 of the 49 (55%) patients fulfilled the Beck's depression criteria of a full remission when they were discharged. At the follow-up interview, 12 months after discharge, 7 of the 27 patients (26%) reported a relapse, while the remaining 20 patients (74%) had stayed relapse-free. The findings of our observational study confirm reports of earlier studies in patients with depression, showing that EMDR therapy leads to a high rate of remission, and is associated with a decreased number of relapses. Patients with depression receiving EMDR treatment may be more resilient to stressors.

SUBMITTER: Altmeyer S 

PROVIDER: S-EPMC9402253 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effectiveness of treating depression with eye movement desensitization and reprocessing among inpatients-A follow-up study over 12 months.

Altmeyer Susanne S   Wollersheim Leonie L   Kilian-Hütten Niclas N   Behnke Alexander A   Hofmann Arne A   Tumani Visal V  

Frontiers in psychology 20220810


Increasing prevalence of depression poses a huge challenge to the healthcare systems, and the success rates of current standard therapies are limited. While 30% of treated patients do not experience a full remission after treatment, more than 75% of patients suffer from recurrent depressive episodes. Eye Movement Desensitization and Reprocessing (EMDR) therapy represents an emerging treatment option of depression, and preliminary studies show promising effects with a probably higher remission ra  ...[more]

Similar Datasets

| S-EPMC10919217 | biostudies-literature
| S-EPMC3901444 | biostudies-literature
| S-EPMC8043524 | biostudies-literature
| S-EPMC9778888 | biostudies-literature
| S-EPMC7144286 | biostudies-literature
| S-EPMC6106867 | biostudies-literature
| S-EPMC4050739 | biostudies-literature
| S-EPMC5081184 | biostudies-literature
| S-EPMC4838623 | biostudies-literature
| S-EPMC10904458 | biostudies-literature